BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27197571)

  • 21. Applying the Fe(III) binding property of a chemical transferrin mimetic to Ti(IV) anticancer drug design.
    Parks TB; Cruz YM; Tinoco AD
    Inorg Chem; 2014 Feb; 53(3):1743-9. PubMed ID: 24422475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of the glycation of transferrin on chromium binding and the transport and distribution of chromium in vivo.
    Deng G; Dyroff SL; Lockart M; Bowman MK; Vincent JB
    J Inorg Biochem; 2016 Nov; 164():26-33. PubMed ID: 27592288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution and chromium-binding capacity of a low-molecular-weight, chromium-binding substance in mice.
    Yamamoto A; Wada O; Ono T
    J Inorg Biochem; 1984 Oct; 22(2):91-102. PubMed ID: 6502162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromium(III) complexes inhibit transcription factors binding to DNA and associated gene expression.
    Raja NS; Nair BU
    Toxicology; 2008 Sep; 251(1-3):61-5. PubMed ID: 18706470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and spectroscopic studies of human melanotransferrin (MTf): electron-paramagnetic resonance evidence for a difference between the iron-binding site of MTf and other transferrins.
    Farnaud S; Amini M; Rapisarda C; Cammack R; Bui T; Drake A; Evans RW; Suryo Rahmanto Y; Richardson DR
    Int J Biochem Cell Biol; 2008; 40(12):2739-45. PubMed ID: 18691669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.
    Baksi S; Tripathi AK; Singh N
    Free Radic Biol Med; 2016 Aug; 97():292-306. PubMed ID: 27343690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aluminum exposure affects transferrin-dependent and -independent iron uptake by K562 cells.
    Pérez G; Pregi N; Vittori D; Di Risio C; Garbossa G; Nesse A
    Biochim Biophys Acta; 2005 Aug; 1745(1):124-30. PubMed ID: 16085060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transferrin-bound and transferrin free iron uptake by cultured rat astrocytes.
    Qian ZM; Liao QK; To Y; Ke Y; Tsoi YK; Wang GF; Ho KP
    Cell Mol Biol (Noisy-le-grand); 2000 May; 46(3):541-8. PubMed ID: 10872741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recycling kinetics and transcytosis of transferrin in primary cultures of bovine brain microvessel endothelial cells.
    Raub TJ; Newton CR
    J Cell Physiol; 1991 Oct; 149(1):141-51. PubMed ID: 1939342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.
    Taetle R; Castagnola J; Mendelsohn J
    Cancer Res; 1986 Apr; 46(4 Pt 1):1759-63. PubMed ID: 3004704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular mechanism for receptor-stimulated iron release from the plasma iron transport protein transferrin.
    Giannetti AM; Halbrooks PJ; Mason AB; Vogt TM; Enns CA; Björkman PJ
    Structure; 2005 Nov; 13(11):1613-23. PubMed ID: 16271884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioadsorption and bioaccumulation of chromium trivalent in Cr(III)-tolerant microalgae: a mechanisms for chromium resistance.
    Pereira M; Bartolomé MC; Sánchez-Fortún S
    Chemosphere; 2013 Oct; 93(6):1057-63. PubMed ID: 23810518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neither human hephaestin nor ceruloplasmin forms a stable complex with transferrin.
    Hudson DM; Krisinger MJ; Griffiths TA; Macgillivray RT
    J Cell Biochem; 2008 Apr; 103(6):1849-55. PubMed ID: 18022819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of transferrin receptor on membrane of erythroblasts in strenuously exercised rats.
    Qian ZM; Xiao DS; Tang PL; Yao FY; Liao QK
    J Appl Physiol (1985); 1999 Aug; 87(2):523-9. PubMed ID: 10444608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway.
    Johnson MB; Chen J; Murchison N; Green FA; Enns CA
    Mol Biol Cell; 2007 Mar; 18(3):743-54. PubMed ID: 17182845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake.
    Richardson DR; Baker E
    J Cell Physiol; 1994 Oct; 161(1):160-8. PubMed ID: 7929602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transferrin and transferrin receptor gene expression and iron uptake in hepatocellular carcinoma in the rat.
    Pascale RM; De Miglio MR; Muroni MR; Simile MM; Daino L; Seddaiu MA; Pusceddu S; Gaspa L; Calvisi D; Manenti G; Feo F
    Hepatology; 1998 Feb; 27(2):452-61. PubMed ID: 9462644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of trace element release during Fe(II)-activated recrystallization of Al-, Cr-, and Sn-substituted goethite and hematite.
    Frierdich AJ; Scherer MM; Bachman JE; Engelhard MH; Rapponotti BW; Catalano JG
    Environ Sci Technol; 2012 Sep; 46(18):10031-9. PubMed ID: 22924460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic insights from the NTP studies of chromium.
    Witt KL; Stout MD; Herbert RA; Travlos GS; Kissling GE; Collins BJ; Hooth MJ
    Toxicol Pathol; 2013 Feb; 41(2):326-42. PubMed ID: 23334696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.